Christine Brideau is on the pre-clinical pharmacology team at Aviko and is a vice president, preclinical pharmacology at Deerfield Discovery and Development. Prior to Deerfield, Christine was vice president of in vitro pharmacology at WuXi AppTec and led the development of WuXi’s US-based in vitro biology unit in New Jersey. Before WuXi, she spent 24 years at Merck, where she most recently served as executive director of in vitro pharmacology and supported multiple drug discovery projects from hit-to-lead to clinical candidate. Christine is the co-author of more than 40 peer-reviewed publications in the areas of pharmacology, assay development, screening day analysis, automation and compound management. She is currently an editorial board member of SLAS Discovery and has served as a reviewer for the NIH Molecular Libraries program study section.